Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells.
Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells. PLoS One. 2020; 15(6):e0234146.
View in:
PubMed
subject areas
Antineoplastic Agents, Immunological
Breast Neoplasms
Cell Line, Tumor
Cell Proliferation
Cell Survival
Drug Resistance, Neoplasm
Epithelial-Mesenchymal Transition
Female
Gene Expression Regulation, Neoplastic
Humans
Receptor, ErbB-2
STAT6 Transcription Factor
Trastuzumab
authors with profiles
Melody Cobleigh
Abde Abukhdeir